Clinical Trial Update: A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Empasiprubart in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Empasiprubart

Snippet

Sponsor: argenx | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Status: RECRUITING